95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.82%
Revenue growth under 50% of PAAS's 21.53%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
27.82%
Gross profit growth under 50% of PAAS's 97.84%. Michael Burry would be concerned about a severe competitive disadvantage.
33.04%
EBIT growth 50-75% of PAAS's 62.72%. Martin Whitman would suspect suboptimal resource allocation.
33.04%
Operating income growth at 50-75% of PAAS's 62.72%. Martin Whitman would doubt the firm’s ability to compete efficiently.
37.61%
Net income growth 1.25-1.5x PAAS's 26.51%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
35.71%
EPS growth 1.25-1.5x PAAS's 27.27%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
35.71%
Diluted EPS growth 1.25-1.5x PAAS's 27.27%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.90%
Share count expansion well above PAAS's 0.11%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.13%
Diluted share count expanding well above PAAS's 0.17%. Michael Burry would fear significant dilution to existing owners' stakes.
-47.91%
Dividend reduction while PAAS stands at 0.05%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
20.34%
OCF growth under 50% of PAAS's 55.03%. Michael Burry might suspect questionable revenue recognition or rising costs.
-582.88%
Negative FCF growth while PAAS is at 306.20%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
179.16%
10Y revenue/share CAGR above 1.5x PAAS's 81.55%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
0.97%
Positive 5Y CAGR while PAAS is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
13.13%
3Y revenue/share CAGR 1.25-1.5x PAAS's 8.84%. Bruce Berkowitz might see better product or regional expansions than the competitor.
185.85%
10Y OCF/share CAGR at 75-90% of PAAS's 224.21%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-22.53%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
9.91%
3Y OCF/share CAGR under 50% of PAAS's 149.98%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
84.25%
Net income/share CAGR above 1.5x PAAS's 30.58% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-50.72%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-13.06%
Negative 3Y CAGR while PAAS is 200.59%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
302.23%
10Y equity/share CAGR above 1.5x PAAS's 43.09%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
57.24%
Positive 5Y equity/share CAGR while PAAS is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
20.67%
Positive short-term equity growth while PAAS is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
46.03%
Stable or rising mid-term dividends while PAAS is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-56.25%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-15.57%
Firm’s AR is declining while PAAS shows 3.20%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
13.75%
Asset growth above 1.5x PAAS's 5.73%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.65%
50-75% of PAAS's 3.18%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
90.51%
We have some new debt while PAAS reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-8.58%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.